Does Medicaid cover Wegovy?
It depends
Wegovy is FDA-approved specifically for chronic weight management, and whether Medicaid covers it depends entirely on whether your state has added the weight-loss indication to its preferred drug list — a growing but still inconsistent group of states.
- Covered when Your state's Medicaid preferred drug list specifically includes Wegovy for weight management, and you meet the BMI and comorbidity documentation prior authorization requires.
- Not when Your state's Medicaid program excludes GLP-1 drugs for the weight-loss indication, even though it may cover the same drug class for diabetes.
- Not when You haven't met prior authorization requirements, such as a documented weight-related condition or evidence of prior diet or lifestyle attempts.
What flips the answer
- Covered when
Your state's Medicaid preferred drug list specifically includes Wegovy for weight management, and you meet the BMI and comorbidity documentation prior authorization requires.
- Not covered when
Your state's Medicaid program excludes GLP-1 drugs for the weight-loss indication, even though it may cover the same drug class for diabetes.
- Not covered when
You haven't met prior authorization requirements, such as a documented weight-related condition or evidence of prior diet or lifestyle attempts.
- Not covered when
A prior authorization renewal is denied because demonstrated weight-loss progress didn't meet your state's reauthorization threshold.
Key facts
- Verdict
- It depends
- Applies to
- Wegovy · Medicaid
- Covered when
- Your state's Medicaid preferred drug list specifically includes Wegovy for weight management, and you meet the BMI and comorbidity documentation prior authorization requires.
- Not covered when
- Your state's Medicaid program excludes GLP-1 drugs for the weight-loss indication, even though it may cover the same drug class for diabetes.
- Varies by state
- Yes
- Verified
- 2026-07-02 · 1 primary source
Wegovy (semaglutide) is approved for chronic weight management in adults with obesity, or overweight plus a weight-related condition — unlike Ozempic, which is approved for type 2 diabetes. Because Medicaid drug coverage is filtered through each state's preferred drug list, and weight-loss drugs have historically faced more scrutiny than diabetes drugs, Wegovy coverage is less consistent than coverage for GLP-1 diabetes medications.
States that do cover Wegovy typically require prior authorization tied to a minimum BMI, a documented weight-related comorbidity, and evidence that lifestyle or diet interventions have already been tried. Some states also require periodic reauthorization showing continued weight-loss progress to keep the prescription covered.
A number of states have specifically excluded GLP-1 drugs for the weight-loss indication from their preferred drug list, even while covering the same drug class for diabetes — so a Wegovy prescription can be denied in a state where Ozempic, for a diabetes diagnosis, would be approved. Because states have been adjusting these policies quickly as GLP-1 costs have grown, check your state's current preferred drug list rather than assuming last year's policy still applies.
Coverage for Wegovy specifically (as opposed to GLP-1 drugs for diabetes) varies widely by state and has been changing quickly. Some states cover it with BMI-based prior authorization criteria; others exclude the weight-loss indication from their preferred drug list entirely. Check your state Medicaid agency's current preferred drug list for the specific policy.
What people typically pay
When a state Medicaid program covers Wegovy and you meet prior authorization, you generally pay little or nothing — Medicaid prescription copays are typically very low, capped by federal rules.
Without coverage, Wegovy's cash price is high and varies widely by pharmacy and any manufacturer discount.
Manufacturer savings cards generally exclude people enrolled in government programs like Medicaid, so the cash price is what applies if your state doesn't cover the weight-loss indication.
How to actually get it covered
Confirm your prescriber has documented your BMI and any weight-related condition in your chart, since prior authorization hinges on these.
Look up your state Medicaid agency's current preferred drug list and confirm Wegovy is listed for weight management — call the Medicaid pharmacy help line if it's unclear.
Have your prescriber submit a prior authorization request that includes your BMI, comorbidity diagnosis, and evidence of prior diet or lifestyle attempts.
Fill the prescription at a Medicaid-enrolled pharmacy once the PA is approved, and confirm the approval covers the full authorization period.
Track your weight-loss progress against your state's reauthorization threshold and have your prescriber submit renewal documentation before the authorization expires.
If denied, ask whether the reason was a missing PA requirement (which you can correct and resubmit) or a state-wide exclusion of the weight-loss indication.
Common questions
How do I find out whether my state's Medicaid covers Wegovy specifically?
Look up your state Medicaid agency's current preferred drug list (PDL) and search for semaglutide or Wegovy under weight management — not diabetes. Many state PDLs are posted online, or you can call the Medicaid pharmacy help line and ask directly whether the weight-loss indication is covered. Because these policies have been changing fast, verify the current version rather than relying on older information.
What does prior authorization for Wegovy usually require?
States that cover Wegovy typically require documentation of a minimum BMI, proof of a diagnosed weight-related comorbidity, and evidence that you already tried diet or lifestyle changes. Your prescriber submits this through a prior authorization request. Some states also require periodic reauthorization showing continued weight-loss progress to keep coverage going. The specific BMI thresholds and criteria vary by state, so check your state's requirements.
My state covers Ozempic for diabetes but denied Wegovy — why?
Ozempic and Wegovy are both semaglutide, but they're approved for different uses: Ozempic for type 2 diabetes and Wegovy for chronic weight management. Many states cover the drug class for diabetes while excluding the weight-loss indication from their PDL, so a Wegovy prescription for weight loss can be denied in the same state that approves Ozempic for a diabetes diagnosis. The denial is about the indication, not the molecule.
What are my options if my Wegovy prescription is denied?
If the denial is because your state excludes weight-loss GLP-1s entirely, there may be no covered pathway to appeal into. If you were denied for missing prior authorization criteria, your prescriber can resubmit with the required BMI, comorbidity, and prior-attempt documentation. You can also ask about manufacturer savings or patient-assistance programs, though those are generally not available to people enrolled in government programs like Medicaid.
Will I lose Wegovy coverage if I don't lose enough weight?
Possibly. Some states tie reauthorization to demonstrated weight-loss progress at renewal. If your progress falls short of your state's threshold, the state can decline to continue coverage. The exact benchmark and timing vary by state, so ask your prescriber what your state's reauthorization standard is before you start.
That's the general answer. Yours is written in your actual policy.
Drop in your policy or benefits document and get the answer for your exact coverage — with the clause it comes from. Nothing is stored.
Check my policy →